Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN119954708A enables mild condition synthesis. Reduces steps and environmental burden for high-purity pharmaceutical intermediate manufacturing supply chains.
Patent CN1362960A details a Lewis acid-catalyzed cyclization for enantiomerically pure PDE4 inhibitors, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115010646B reveals visible light induced cyclization for indolone compounds. Offers mild conditions and scalable production for pharmaceutical intermediates.
Advanced synthesis of 6-methoxycarbonyl indolone via patent CN102267934A. Offers high purity, reduced toxicity, and scalable manufacturing for pharmaceutical intermediates.
Patent CN120647657A reveals metal-free visible light synthesis for sulfonylated benzazepine indolones. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Novel method for chiral 3-fluoro-2-indolone derivatives via Ellman imine addition. High yield, mild conditions, scalable for API intermediates.
Patent CN108997362B reveals a cost-effective one-pot synthesis for pyranoindolone fused medium-rings, eliminating precious metals for reliable pharmaceutical intermediate supply.
Patent CN110256496B reveals a mild copper-catalyzed route to beta-thioindolones, offering safer alternatives to toxic CS2 methods for reliable pharmaceutical intermediate supply chains.
Patent CN116668C details a novel weak Lewis acid catalyzed cyclization for high-purity PDE4 inhibitor intermediates, offering significant cost and supply chain advantages.
Novel iodine-mediated water-based synthesis offers safe scalable production for pharmaceutical intermediates with reduced costs and enhanced supply chain reliability for global buyers
Patent CN111057062A details a green phosphotungstic acid catalyzed route for spiro indolone, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN118084876A reveals a concise Pauson-Khand route for indole skeletons. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel synthetic route for Ziprasidone intermediate using toluylic acid. High yield, low cost, scalable process for pharmaceutical manufacturing supply chains.
Patent CN103570604B reveals a cost-effective 3-step route for 6-chloro-2-indolone. Enhance supply chain reliability and reduce manufacturing costs for Ziprasidone intermediates.
Patent CN119874717A reveals mild synthesis for antitumor intermediates. Enables cost reduction in pharmaceutical manufacturing with high purity and scalable supply chain reliability for global buyers.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Novel copper-catalyzed route for 2-indolones offers high yield and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN114874127B details a cost-effective nickel-catalyzed method for difluorocarbonylated indolones, offering significant supply chain and purity advantages.
Efficient copper-catalyzed synthesis of quaternary carbon center indolones. Mild conditions, high yield, scalable for pharmaceutical intermediates supply chain.
Patent CN111153889B reveals potent VEGFR-2 inhibitors. We offer scalable synthesis for high-purity pharmaceutical intermediates with optimized cost efficiency.